In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...

Shares of Bio-Techne Corp. shed 3.71% to $71.83 Wednesday, on what proved to be an all-around dismal trading session for the ...

On January 23, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.